TrialInflammatory bowel diseases2019

Vedolizumab in Combination With Corticosteroids for Induction Therapy in Crohn's Disease: A Post Hoc Analysis of GEMINI 2 and 3.

Bruce E Sands et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.